2018 and Beyond: Portugal Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Portugal witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Portugal and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Portugal healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Portugal healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Portugal pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Portugal and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Portugal healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Portugal healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Portugal pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Portugal Pharmaceutical and Healthcare Industry Snapshot
2.2 Portugal Pharmaceuticals Market Overview
3 PORTUGAL PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Portugal
3.2 Drivers and Restraints
3.2.1 Market Drivers in Portugal Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Portugal Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 PORTUGAL PHARMACEUTICAL MARKET OUTLOOK
4.1 Portugal Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Portugal Pharmaceutical Exports, $ million, 2015- 2025
4.3 Portugal Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Portugal (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Portugal (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Portugal Prescription Drug Sales, $ Million, 2015- 2025
4.7 Portugal Generic Drug Sales, $ Million, 2015- 2025
5 PORTUGAL HEALTHCARE MARKET OUTLOOK
5.1 Portugal Healthcare Expenditure Outlook, 2015- 2025
5.2 Portugal Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Portugal Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Portugal Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Portugal, 2015- 2025
6 PORTUGAL HEALTHCARE MARKET STATISTICS
6.1 Portugal Mortality by Disease Category, 2017
6.2 Number of Hospitals in Portugal, 2007- 2017
6.3 Number of Hospital Beds in Portugal, 2007- 2017
6.4 Physicians Count in Portugal, 2007- 2017
6.5 Pharmacists Count in Portugal, 2007- 2017
7 PORTUGAL CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Portugal, 2017
7.2 Ongoing Clinical Trials by Disease Category in Portugal, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 PORTUGAL DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Portugal Population Forecast by Age Group, 2005- 2025
8.2 Portugal Population Forecast by Location, 2005- 2025
8.3 Portugal GDP Forecast, 2005- 2025
8.4 Portugal GDP Per Capita Forecast, 2005- 2025
8.5 Portugal Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN PORTUGAL PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Portugal Pharmaceutical and Healthcare Industry Snapshot
2.2 Portugal Pharmaceuticals Market Overview
3 PORTUGAL PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Portugal
3.2 Drivers and Restraints
3.2.1 Market Drivers in Portugal Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Portugal Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 PORTUGAL PHARMACEUTICAL MARKET OUTLOOK
4.1 Portugal Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Portugal Pharmaceutical Exports, $ million, 2015- 2025
4.3 Portugal Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Portugal (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Portugal (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Portugal Prescription Drug Sales, $ Million, 2015- 2025
4.7 Portugal Generic Drug Sales, $ Million, 2015- 2025
5 PORTUGAL HEALTHCARE MARKET OUTLOOK
5.1 Portugal Healthcare Expenditure Outlook, 2015- 2025
5.2 Portugal Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Portugal Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Portugal Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Portugal, 2015- 2025
6 PORTUGAL HEALTHCARE MARKET STATISTICS
6.1 Portugal Mortality by Disease Category, 2017
6.2 Number of Hospitals in Portugal, 2007- 2017
6.3 Number of Hospital Beds in Portugal, 2007- 2017
6.4 Physicians Count in Portugal, 2007- 2017
6.5 Pharmacists Count in Portugal, 2007- 2017
7 PORTUGAL CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Portugal, 2017
7.2 Ongoing Clinical Trials by Disease Category in Portugal, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 PORTUGAL DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Portugal Population Forecast by Age Group, 2005- 2025
8.2 Portugal Population Forecast by Location, 2005- 2025
8.3 Portugal GDP Forecast, 2005- 2025
8.4 Portugal GDP Per Capita Forecast, 2005- 2025
8.5 Portugal Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN PORTUGAL PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
